Agile Therapeutics Inc. (AGRX)

NASDAQ: AGRX · Real-Time Price · USD

1.51

0.05 (3.42%)

At close: Aug 22, 2024, 7:58 PM

Agile Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-14.46M	-25.41M	-74.89M	-51.85M	-18.61M	-19.78M	-28.3M	-28.74M
Depreciation & Amortization	386K	1.53M	2.22M	276K	163K	23K	23K	19K
Stock-Based Compensation	1.98M	2.49M	3.34M	2.82M	1.76M	3.63M	3.65M	3.42M
Other Working Capital	9.64M	705K	-1.1M	972K	-385K	155K	2.01M	922K
Other Non-Cash Items	1.06M	-12.43M	1.66M	1.34M	711K	282K	667K	946K
Deferred Income Tax	-5.96M	n/a	5.32M	n/a	-711K	-29K	-143K	-234K
Change in Working Capital	7.42M	-2.13M	-2.85M	107K	992K	-1.02M	-454K	1.28M
Operating Cash Flow	-9.58M	-35.95M	-65.2M	-47.31M	-15.69M	-16.89M	-24.56M	-23.3M
Capital Expenditures	n/a	-133K	-269K	-353K	-98K	-318K	-1.31M	-31K
Cash Acquisitions	n/a	n/a	n/a	353K	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-54.84M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	39.73M	14.5M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-133K	39.73M	-353K	-147K	-318K	-1.55M	-31K
Investing Cash Flow	n/a	-133K	39.46M	-40.69M	-98K	-318K	-1.31M	-31K
Debt Repayment	-1.35M	-17.38M	n/a	20M	n/a	-10.89M	-5.61M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.29M	n/a	75K	-449K	42.41M	n/a	152K	159K
Financial Cash Flow	6.89M	22.18M	30.42M	67.98M	42.41M	-10.89M	13.07M	37.69M
Net Cash Flow	-2.69M	-13.9M	4.68M	-20.02M	26.63M	-28.1M	-12.8M	14.36M
Free Cash Flow	-9.58M	-36.08M	-65.47M	-47.66M	-15.79M	-17.21M	-25.87M	-23.33M